Announcements Trials
Browse Landscape

Phase

Phase 2 11Phase 1 7Phase 1/2 3Phase EARLY_PHASE1 2Phase NA 1Phase 3 1Phase 2/3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Carcinoma, Non-Small-Cell Lung 5Neoplasms 3Recurrence 1Pancreatic Neoplasms 1Oligometastatic Lung Adenocarcinoma 1Neoplasm Metastasis 1NSCLC 1Lung Neoplasms 1Head and Neck Neoplasms 1Glioma 1Gastrointestinal Neoplasms 1EGFR Mutation Positive Non-small Cell Lung Cancer 1Carcinoma 1Breast Neoplasms 1

Interventions

Surveys and Questionnaires 14Low-Level Light Therapy 13Standard of Care 11Radiotherapy 11Magnetic Resonance Spectroscopy 10Radiotherapy, Intensity-Modulated 8Exercise 8Blood Specimen Collection 8Magnetic Resonance Imaging 7Cisplatin 6Radiosurgery 5Immunohistochemistry 5Fluorodeoxyglucose F18 5Biopsy 5X-Rays 4Transcutaneous Electric Nerve Stimulation 4Therapeutics 4Radiation 4Practice Guidelines as Topic 4Methods 4Equipment and Supplies 4Educational Status 4Cetuximab 4fluoromisonidazole 3Tomography, X-Ray Computed 3Resistance Training 3Radiotherapy, Image-Guided 3Preoperative Exercise 3Positron-Emission Tomography 3Nicotine 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Head and Neck Neoplasms × Erlotinib Hydrochloride × Clear all
NCT00144976 2015-03-27

Study of Biological Effect of Tarceva (OSI-774) for Patients Stricken by ENT Epidermoid Carcinoma

Institut Claudius Regaud

Phase NA Completed
43 enrolled
Head & Neck

Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡